Table 3 The adjusteda association between the selection of cryotherapy instead of aggressiveb standard therapies in men diagnosed with incident localized prostate cancer, SEER-Medicare

From: Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study

NCCN criterion c

OR

95% CI

P-value

High

0.70

(0.51, 0.96)

0.026

Intermediate

1.00

(0.80, 1.26)

0.986

Low

 

Referent

 
  1. Abbreviations: CI, confidence interval; NCCN, The National Comprehensive Cancer Network; OR, odds ratio; SEER, Surveillance Epidemiology End Results.
  2. aAdjusted for age, race, marital status, income, region and Charlson co-morbidity score.
  3. bAggressive standard therapies include radical prostatectomy, external beam radiation therapy and brachytherapy.
  4. cPatients were categorized into three risk groups on the basis of clinical classification, PSA level and Gleason score: low-risk (T1-T2a and PSA level <10 ng ml−1 and Gleason score 2–6), intermediate-risk (T2b-T2c or 10⩽PSA ⩽20 ng ml−1 or Gleason score=7) and high-risk (PSA level >20 ng ml−1 or Gleason score 8–10).
Back to article page